April 7, 2010 - The lack of radiation therapy treatment African-American women receive is not responsible for the poorer survival noted among African-American patients.

According to a new study by researchers at University of California-Davis, African-American women have poorer survival rates than their white and Hispanic counterparts regardless of whether they receive radiation therapy following lumpectomy or mastectomy.

Steve Martinez, a surgical oncologist, and assistant professor of surgery at UC Davis Cancer Center, determined that while Hispanic and African-American women with advanced breast cancer are less likely to receive radiation therapy than their white counterparts, only African Americans have poorer outcomes than white patients with the same stage disease.

Martinez looked at data from more than 12,000 women from throughout the country who had breast cancer that had spread to 10 or more lymph nodes and that had resulted in either lumpectomy or mastectomy.

he found was that Hispanic patients were 20 percent less likely to get radiation therapy than their white counterparts, and black patients were about 24 percent less likely to receive radiation therapy.

For the second study, he wanted to learn whether the disparities in receipt of radiation therapy resulted in poorer outcomes for Hispanic and African-American women.

Martinez examined 10-year survival rates in patients from each group who received radiation therapy and those who did not. While he found dramatic differences in survival for white women who had radiation therapy (an 11 percent survival boost), black patients had just a 3 percent difference in their survival rates.

Martinez plans to continue his research into factors that may influence whether or not patients receive radiation therapy and that may also affect their outcomes, including possible biological differences.

Martinez said his team is trying to determin which treatments work best for which people.

For more information: www.ucdmc.ucdavis.edu


Related Content

News | Stereotactic Body Radiation Therapy (SBRT)

Sept. 27, 2026 — Siemens Healthineers recently launched Accela, a radiotherapy solution engineered around NeoArc ...

Time October 01, 2026
arrow
News | Ultrasound Women's Health

Sept. 29, 2026 — A research team at the University of Virginia (UVA) led by Timothy Bullock, PhD, has published results ...

Time September 30, 2026
arrow
News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
News | Proton Therapy

Sept. 28, 2026 — Penn Medicine and Ion Beam Applications (IBA) have formed Noventra Oncology Alliance, a new joint ...

Time September 28, 2026
arrow
News | ASTRO

Sept. 22, 2026 — Leading experts in radiation therapy from the Abramson Cancer Center (ACC) of the University of ...

Time September 24, 2026
arrow
News | Computed Tomography (CT)

Sept. 17, 2026 — Royal Philips and Southwest Mississippi Regional Medical Center (SMRMC), which serves as the hub of ...

Time September 24, 2026
arrow
News | ASTRO

Sept.16, 2026 — For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a ...

Time September 17, 2026
arrow
News | Radiology Education

Sept. 16, 2026 — As urgent care centers and outpatient healthcare facilities expand their use of diagnostic imaging, the ...

Time September 17, 2026
arrow
News | PET Imaging

Sept. 10, 2026 — Siemens Healthineers Molecular Imaging has completed a $43.6 million construction and renovation ...

Time September 14, 2026
arrow
News | Radiology Imaging

Sept. 1, 2026 — Leo Cancer Care and GE HealthCare have announced that the two companies intend to work together on GE ...

Time September 11, 2026
arrow
Subscribe Now